Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2016, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2016-02-17
DOI
10.1155/2016/9512743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-inflammatory Activity of Saxifragin via Inhibition of NF-κB Involves Caspase-1 Activation
- (2015) Se-Yun Cheon et al. JOURNAL OF NATURAL PRODUCTS
- Roles of Oxidative Stress in the Development and Progression of Breast Cancer
- (2014) Ali Reza Nourazarian et al. Asian Pacific Journal of Cancer Prevention
- Apoptotic effects of proteasome and histone deacetylase inhibitors in prostate cancer cell lines
- (2014) I. Kiliccioglu et al. GENETICS AND MOLECULAR RESEARCH
- TNF-α promotes gallbladder cancer cell growth and invasion through autocrine mechanisms
- (2014) GUANGWEI ZHU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer
- (2014) Clelia Madeddu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Anti-Fibrotic Actions of Interleukin-10 against Hypertrophic Scarring by Activation of PI3K/AKT and STAT3 Signaling Pathways in Scar-Forming Fibroblasts
- (2014) Jihong Shi et al. PLoS One
- Chronic Inflammation and Cytokines in the Tumor Microenvironment
- (2014) Glauben Landskron et al. Journal of Immunology Research
- Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo
- (2013) Wenwen Chien et al. MOLECULAR CARCINOGENESIS
- Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?
- (2013) Marco Tafani et al. Frontiers in Pharmacology
- Oxidative stress and cancer: An overview
- (2012) Venus Sosa et al. AGEING RESEARCH REVIEWS
- TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells
- (2012) Sung Hee Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Influence of functional genetic polymorphism (−590C/T) in non-small cell lung cancer (NSCLC) development: The paradoxal role of IL-4
- (2012) Mónica Gomes et al. GENE
- The tumor microenvironment in hepatocellular carcinoma (Review)
- (2012) Massimo Libra INTERNATIONAL JOURNAL OF ONCOLOGY
- Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias
- (2012) Gabriela Bottaro Gelaleti et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer
- (2011) Denis Drygin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition
- (2011) Gali Soria et al. BMC CANCER
- Role of interleukin-10 in breast cancer
- (2011) Hamidullah et al. BREAST CANCER RESEARCH AND TREATMENT
- Gallotannin inhibits NFĸB signaling and growth of human colon cancer xenografts
- (2011) Racha Al-Halabi et al. CANCER BIOLOGY & THERAPY
- IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
- (2011) John B. Mumm et al. CANCER CELL
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- Inhibiting NF-κB activation by small molecules as a therapeutic strategy
- (2010) Subash C. Gupta et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- Paradoxical Roles of IL-4 in Tumor Immunity
- (2010) Zhiguang Li et al. Cellular & Molecular Immunology
- Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70
- (2010) Mark C. Heckel et al. CELLULAR IMMUNOLOGY
- Pharmacokinetic and Pharmacodynamic Modeling of an Anti-Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma
- (2010) T. Puchalski et al. CLINICAL CANCER RESEARCH
- The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
- (2009) Kellie A. Charles et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas
- (2008) S. Kim et al. CANCER RESEARCH
- NF-κB and cancer—identifying targets and mechanisms
- (2008) Willscott E Naugler et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cytokines as a key component of cancer-related inflammation
- (2008) Giovanni Germano et al. CYTOKINE
- The tumor microenvironment and its contribution to tumor evolution toward metastasis
- (2008) Girieca Lorusso et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Tumor-host interactions: the role of inflammation
- (2008) Marie-Aude Bitoux et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started